These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4444228)

  • 1. [Pharmacocinetics and dosage of dextran 40 in relation to renal function (author's transl)].
    Köhler H; Kirch W; Höffler D; Koeppe P
    Klin Wochenschr; 1974 Dec; 52(23):1111-6. PubMed ID: 4444228
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dosage and elimination of Dextran 40 in patients on hemodialysis (author's transl)].
    Köhler H; Weihrauch TR; Fiegel P; Kirch W; Höffler D
    Klin Wochenschr; 1975 Jun; 53(11):523-7. PubMed ID: 1152343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of kidney in maintenance of mineral and water balance in renal failure (author's transl)].
    Válek A
    Cas Lek Cesk; 1975 Mar; 114(10-11):303-6. PubMed ID: 1139572
    [No Abstract]   [Full Text] [Related]  

  • 4. [Calcium metabolism in chronic uraemia and in patients on chronic intermittent haemodialysis (author's transl)].
    Skrabal F; Dittrich P
    Wien Klin Wochenschr; 1974 Apr; 86(7):169-77. PubMed ID: 4207089
    [No Abstract]   [Full Text] [Related]  

  • 5. [Iatrogenic generalized storage of dextran in regularly dialyzed patients].
    Stejskalová A; Stejskal J; Elleder M
    Cesk Patol; 1986 Mar; 22(1):1-9. PubMed ID: 2420481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of intravenous Cefradin in normal and restricted renal function (author's transl)].
    Höffler D; Koeppe P
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1169-74. PubMed ID: 808712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of 6% hydroxyethyl starch 450/0.7, 10% dextran 40 and 3.5% gelatin on plasma volume in patients with terminal renal failure (author's transl)].
    Köhler H; Kirch W; Klein H; Distler A
    Anaesthesist; 1978 Sep; 27(9):421-6. PubMed ID: 82409
    [No Abstract]   [Full Text] [Related]  

  • 8. Human glomerular membrane porosity and filtration pressure: dextran clearance data analysed by theoretical models.
    Arturson G; Groth T; Grotte G
    Clin Sci; 1971 Feb; 40(2):137-58. PubMed ID: 5548520
    [No Abstract]   [Full Text] [Related]  

  • 9. Sulfate regulation: native kidney vs dialysis.
    Kirschbaum B
    Int J Artif Organs; 1999 Sep; 22(9):591-2. PubMed ID: 10532426
    [No Abstract]   [Full Text] [Related]  

  • 10. Dextran deposits in tissues of patients undergoing haemodialysis.
    Bergonzi G; Paties C; Vassallo G; Zangrandi A; Poisetti PG; Ballocchi S; Fontana F; Scarpioni L
    Nephrol Dial Transplant; 1990; 5(1):54-8. PubMed ID: 1691467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemofiltration in patients with chronic renal failure (author's transl)].
    Morales J; Fuentes P; James E; Zehnder C; de Halleux C; Thielemann I; Andaur V; Artigas G; Saavedra B; Morales I; Pérez E
    Rev Med Chil; 1978 Jul; 106(7):511-4. PubMed ID: 694275
    [No Abstract]   [Full Text] [Related]  

  • 12. [Beta2-microglobulin levels in patients with renal disease on chronic hemodialysis (author's transl)].
    Yorioka N; Onari K; Akiyama M; Yamakido M; Nishimoto Y
    Rinsho Byori; 1976 Sep; 24(9):765-9. PubMed ID: 63578
    [No Abstract]   [Full Text] [Related]  

  • 13. The renal handling of dextran 40 by surgical patients.
    Heale WF; Niall JF; Doyle JC
    Aust N Z J Surg; 1968 Nov; 38(2):168-72. PubMed ID: 5247982
    [No Abstract]   [Full Text] [Related]  

  • 14. [Circulatory and metabolic changes during submaximum exertion in patients with chronic renal failure treated by regular dialysis (author's transl)].
    Tomásek R; Lisý Z; Válek A; Pick P; Straková M
    Sb Lek; 1975 Sep; 77(9):278-88. PubMed ID: 1179147
    [No Abstract]   [Full Text] [Related]  

  • 15. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
    Ohnhaus EE; Spring P; Dettli L
    Dtsch Med Wochenschr; 1974 Sep; 99(37):1797-803. PubMed ID: 4457307
    [No Abstract]   [Full Text] [Related]  

  • 16. [Secondary hyperparathyroidism: especially in chronic renal failure (author's transl)].
    Tomita A
    Horumon To Rinsho; 1981 Nov; 29(11):1343-9. PubMed ID: 7341000
    [No Abstract]   [Full Text] [Related]  

  • 17. [Renal function after acute renal failure (author's transl)].
    Fuchs HJ; Thelen M; Wilbrandt R
    Dtsch Med Wochenschr; 1974 Aug; 99(33):1641-4. PubMed ID: 4843640
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of dialysis-induced leukopenia and hypoxemia by using low-molecular dextran].
    Wanic-Kossowska M
    Pol Arch Med Wewn; 1990 Jul; 84(1):16-22. PubMed ID: 1701247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cefamandol: pharmacokinetics with normal and impaired renal function (author's transl)].
    Höffler D; Moecke D; Sassmann M
    Dtsch Med Wochenschr; 1978 Aug; 103(34):1334-8. PubMed ID: 679835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of clearance values in advanced renal insufficiency (author's transl)].
    Mertz DP
    MMW Munch Med Wochenschr; 1978 Oct; 120(43):1419-24. PubMed ID: 101802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.